• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2313C145E
Medical Device Problem Code Occlusion Within Device (1423)
Health Effect - Clinical Codes Embolus (1830); Occlusion (1984); Pain (1994)
Date of Event 03/16/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment an abdominal aortic dissection.It was reported that during a recent follow up a ct revealed that the endurant stent graft was occluded.The patient had a secondary intervention.The physician could access the occluded endurant stent graft with ivus however there was no evidence of compression or kinking.There was well established thrombosis and there were no endovascular treatment available to treat the occlusion, as there was no mechanical issue observed.The physician preformed a femoral to femoral bypass, and the blood flow was restored.The physician stated that the cause of the event could not be determined, as there were no kinks or compression noted.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information was received.The patient has experienced pain and other blood clots.
 
Additional Manufacturer Narrative
Corrected information: sex, date of birth.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key6486942
Report Number2953200-2017-00573
Device Sequence Number1289793
Product Code MIH
UDI-Device Identifier00613994991171
UDI-Public00613994991171
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/17/2018
Device Model NumberETBF2313C145E
Device Catalogue NumberETBF2313C145E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/21/2017
Supplement Date Received by ManufacturerNot provided
04/14/2017
Initial Report FDA Received Date04/12/2017
Supplement Report FDA Received Date05/12/2017
10/02/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
-
-